MAY 27, 2025
Press release: Sensome announces enrollment completion in First-in-Human study of in situ tumor detection system for lung cancer.
​
​
DEC 13, 2024
Press release: Sensome announces data from two new studies showing clot-sensing guidewire successfully identifies fresh clot to support decision-making in peripheral artery disease treatment.
​
​
SEP 10, 2024
Press release: Sensome announces first patients enrolled in first-in-human study evaluating feasibility of real-time, in situ tumor confirmation system for lung cancer.
​
JUL 10, 2024
Press release: Sensome signs exclusive commercial distribution agreement for clot-sensing guidewire in Japan with Cosmotec.
​
​
JUN 5, 2024
Press release: First-In-Human data for Sensome clot-sensing guidewire used in ischemic stroke treatment demonstrate ability to automate clot characterization with no safety issues.
FEB 12, 2024
Press release: Sensome announces initiation of clinical trial assessing its tissue microsensor technology in peripheral artery disease.
​
​
JUN 21, 2023
Press release: Sensome and ASAHI INTECC forge partnership to develop next-generation smart guidewire and transform stroke treatment.
​
​
NOV 29, 2022
Press release: Sensome wins “EUROPEAN AWARDS IN MEDICINE” Prize.
​
​
​
SEP 13, 2021
Press release: Sensome begins human trial for its AI-powered Stroke Guidewire.
EN version
FR Version
JUN 21, 2021
Press release: Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire.
EN Version
FR Version
JAN 13, 2020
Press release: Sensome raises $9 million B round with equity investment from ASAHI INTECC, The two companies start development program to integrate Sensome’s tissue micro-sensor into Asahi’s world class guidewire.
EN Version
FR Version
JUN 11, 2018
Press release: Sensome raises €4.6 million to bring the first connected stroke device to market.
EN version
FR version
NOV 20, 2017
Press release: Sensome renforce sa gouvernance avec les vétérans de l'industrie, des institutions
de recherche prestigieuses deviennent des actionnaires.
FR version
JUL 10, 2017
Press release: Sensome, formerly Instent, raises €4.7 million to bring the world’s first connected stroke guidewire to patients​.
EN version
FR version